US Broker Ratings

Integra LifeSciences Holdings (IART) Stock Analysis: Navigating a 24.51% Potential Upside Amidst Industry Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector, particularly in the medical devices industry, presents a complex yet intriguing picture for..

Apellis Pharmaceuticals (APLS) Stock Analysis: Navigating a 58% Potential Upside in the Biotech Sector

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a compelling name for investors eyeing opportunities in the healthcare sector’s biotechnology industry. With a market capitalization of $3.01 billion,..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Unpacking the 74% Potential Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has captured the attention of the investor community with its remarkable potential upside of 74.22%, according to analyst ratings. As a..

Astrana Health Inc. (ASTH) Stock Analysis: Tapping Into a 52.98% Potential Upside

Astrana Health Inc. (ASTH), a burgeoning name in the healthcare sector, is capturing investor attention with its promising revenue growth and substantial potential upside. The company’s..

Structure Therapeutics Inc. (GPCR): Unveiling a 317% Potential Upside for Investors

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing the attention of investors with its promising pipeline and a remarkable potential upside of 317.34%. This clinical-stage biopharmaceutical company,..

Indivior PLC (INDV) Stock Analysis: Unlocking a 22.63% Potential Upside in the Healthcare Sector

Indivior PLC (INDV) stands out in the healthcare sector as a promising investment, primarily due to its focus on developing and manufacturing prescription drugs aimed at..

Artivion, Inc. (AORT) Stock Analysis: Navigating Growth Amidst a 15.3% Revenue Surge in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT) has been capturing investor attention as it stands at the cusp of a promising growth trajectory within the healthcare sector. With a..

Surgery Partners, Inc. (SGRY) Stock Analysis: A 36% Upside Awaits Investors in Healthcare

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, particularly in the medical care facilities industry. Headquartered in Brentwood, Tennessee, this U.S.-based company..

Harmony Biosciences Holdings, Inc. (HRMY): Key Insights into a Promising 45% Upside in the Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a burgeoning name in the biotechnology sector, is capturing attention with its robust pipeline and significant potential upside. As a..

Sotera Health Company (SHC) Stock Analysis: Riding a 13.8% Upside Potential in Healthcare Innovation

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, focusing on diagnostics and research. With a market capitalization of $3.99 billion,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 23% Potential Upside

For investors seeking exposure in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing opportunity, particularly with a potential upside of 23.21% based..

Bausch Health Companies Inc. (BHC) Stock Analysis: A Closer Look at Its 6.36% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare industry, has been making waves in the market with a current stock price of..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 42.72% Potential Upside in the Healthcare Sector

Omnicell, Inc. (NASDAQ: OMCL) operates at the intersection of healthcare and technology, providing innovative medication management solutions aimed at improving clinical workflows and patient safety. With..

NewAmsterdam Pharma (NAMS): Investor Outlook Reveals a Promising 64.61% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS) has emerged as a prominent player in the biotechnology sector, attracting investor attention with its promising drug pipeline and significant upside..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Exploring a Potential 153% Upside in Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands as a compelling opportunity in the healthcare sector, particularly for investors with a focus on biotechnology. The company, headquartered in..

Centessa Pharmaceuticals plc (CNTA) Stock Analysis: Unveiling a 94.66% Potential Upside in Biotech

Investors with an eye for healthcare innovation and potential high returns may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) a compelling opportunity. The UK-based biotechnology company, with..

Novavax, Inc. (NVAX) Stock Analysis: Navigating a 63.67% Potential Upside Amid Biotech Volatility

In the ever-evolving landscape of biotechnology, Novavax, Inc. (NASDAQ: NVAX) stands out with its innovative approach to vaccine development. As a key player in the healthcare..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a 21.85% Potential Upside in Healthcare Innovation

10x Genomics, Inc. (NASDAQ: TXG), a pioneering entity in the healthcare sector, specializes in developing advanced life science technology that enables comprehensive biological system analysis. With..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 121.96% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a Potential 125% Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a dynamic player in the biotechnology sector, has drawn significant attention from investors eager to capitalize on its promising pipeline and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds